Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism FLT3 inhibitors(Tyrosine-protein kinase receptor FLT3 inhibitors), VEGFR antagonists(Vascular endothelial growth factor receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC33H38N8O4S |
InChIKeyMAFACRSJGNJHCF-UHFFFAOYSA-N |
CAS Registry895533-09-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 1 | - | - | |
Acute Myeloid Leukemia | Phase 1 | - | - | |
Solid tumor | Phase 1 | DE | - |